Company Allena Pharmaceuticals, Inc.
Equities
ALNA
US0181191075
Biotechnology & Medical Research
Business Summary
Number of employees: 12
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 71 | 11-06-23 | |
Chief Operating Officer | - | 17-12-31 | |
Hugh Wight
CTO | Chief Tech/Sci/R&D Officer | - | - |
Matthew Foster
PRN | Corporate Officer/Principal | - | 22-09-01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 11-06-23 | |
Director/Board Member | 61 | 21-04-05 | |
Ann Miller
BRD | Director/Board Member | 66 | 20-10-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 122,083,226 | 120,964,626 ( 99.08 %) | 0 | 99.08 % |
Company contact information
Allena Pharmaceuticals, Inc.
142-F North Road Suite 150
01776, Sudbury
+617 467 4577
http://www.allenapharma.comSector
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |